Celecoxib and rofecoxib: efficacy and safety of selective inhibitors of Cox-2 compared to non-selective NSAIDs. (2004). Portuguese Journal of Family Medicine and General Practice, 20(1), 47-64. https://doi.org/10.32385/rpmgf.v20i1.10008